Therapeutic use of factor XI

Details for Australian Patent Application No. 2004290869 (hide)

Owner Novo Nordisk Health Care AG

Inventors Jensen, Simon Bjerregaard; Viuff, Dorthe; Rojkjaer, Rasmus; Hansen, Jens Jacob; Ostergaard, Soren

Agent Shelston IP

Pub. Number AU-A-2004290869

PCT Pub. Number WO2005/049070

Priority PA 2003 01721 20.11.03 DK; PA 2004 01141 23.07.04 DK

Filing date 22 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/049070 Priority application(s): WO2005/049070

4 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290874-Use of cathepsin K inhibitors in severe bone loss diseases

2004290868-A method and process for controlling the temperature, pressure-and density profiles in dense fluid processes